HF 384 (see companion bill SF 1029) – Minnesota

Status: In Process
Year Introduced: 2023
Link: https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF0384&ssn=0&y=2023

This bill prohibits a health plan company from restricting an enrollee’s choice regarding where the enrollee receives services for the diagnosis, monitoring, and treatment of a rare disease or condition, and prohibits cost-sharing or limitations on diagnosing or treating a rare disease or condition that place a greater financial burden on the enrollee or are more restrictive than requirements for in-network care. It also requires medical assistance coverage for diagnosis, monitoring, and treating a rare disease or condition to comply with these requirements.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found